Research Compound Profile
Tirzepatide
Dual GIP / GLP-1 receptor agonist
Technical Info
Tirzepatide activates two incretin pathways involved in appetite, glucose regulation, insulin sensitivity, and body weight research.
Explain It Like I’m 10
The double messenger. GLP-1 says “we’re full” while GIP helps the body use fuel smarter.
Pros / Research Interest
- Reduced appetite
- Improved glucose regulation
- Better metabolic efficiency
- Reduced snacking
Potential Side Effects
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Acid reflux
- Injection site reactions
JAKU Research Note
Tirzepatide content is presented for education and research discussion only. It should not be used as medical guidance or treatment advice.